相关实验视频
Updated: Jan 11, 2026

19:32
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
29.0K
在早产婴儿的咖啡因启动的指示和时间
Franciszek Borys1,2, Katarzyna Wróblewska-Seniuk1, Michelle Fiander3
1II Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
The Cochrane database of systematic reviews
|November 11, 2025
概括
对于早产婴儿来说,最佳的咖啡因启动时间尚不清楚. 虽然早期咖啡因 (72小时内) 可能会减少慢性肺病和呼吸暂停,但其他结果和时间的证据非常不确定.
科学领域:
- 新生儿医学 新生儿医学
- 药理学 药理学是指药理学的学科.
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 咖啡因被广泛用于提高早产婴儿的呼吸功能.
- 启动咖啡因治疗的最佳策略,包括时间和适应症,尚未明确.
- 本次审查解决了对这种脆弱人群的咖啡因管理的基于证据的指导方针的需求.
研究的目的:
- 系统地评估不同咖啡因启动策略在早产婴儿的比较益处和危害.
- 评估时间 (例如,在2小时内,在72小时内) 和指示 (例如,机械通风与输出管) 对关键和重要结果的影响.
主要方法:
- 在主要数据库 (MEDLINE,Embase,CENTRAL) 和试验注册表中进行了全面的搜索,直到2025年4月.
- 包括随机对照试验 (RCT),集群RCT和准RCT,比较各种咖啡因启动协议.
- 使用固定效应模型进行了元分析,使用GRADE方法评估证据确定性.
主要成果:
- 关于早期咖啡因开始 (在2小时或72小时内) 对慢性肺病 (CLD) 和机械通风 (DMV) 持续时间的影响的证据非常不确定.
- 在72小时内开始服用咖啡因 (C72H) 可能会减少CLD和呼吸暂停,有中等确定性的证据.
- 在机械通风过程中开启咖啡因可能会减少CLL和DMV,但对死亡率的证据非常不确定.
结论:
- 在早产婴儿中提升咖啡因的最佳时间和指示需要进一步调查,因为许多比较的证据非常不确定.
- 咖啡因在72小时内开始似乎有利于减少CLD和呼吸暂停,尽管需要更多的研究.
- 目前正在进行的研究预计将提供更明确的证据,可能会改变目前的结论.
更多相关视频
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Drug Dosing: Infants and Children
237
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
237
Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K

